Adalimumab a PREMIER treatment for early rheumatoid arthritis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1466, 2004-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adalimumab is an effective option in the treatment of patients with refractory rheumatoid arthritis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 4, 2005-04 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Adalimumab effective for juvenile rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

By Poddubnyy Denis   Rudwaleit Martin  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab: real life efficacy in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1454, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Adalimumab improves symptoms and QOL in rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite